HSR25-178: Initial Clinical Presentation (ICP) and Pre-Diagnostic Journey During 18 Months Before a First Non-Small Cell Lung Cancer (NSCLC) Diagnosis: US Retrospective Cohort Study
Year: 2025
Type: article
Study design: Observational Study
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408938682
